Why the Elixinol (ASX:EXL) share price has been halted today?

The Elixinol (ASX:EXL) share price remains in a trading halt today as the company plans a potential transaction. We take a closer look.

| More on:
ASX share price trading halt represented by serious woman putting hand up

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Elixinol Global Ltd (ASX: EXL) share price has been halted today as the company reported that it would be announcing a potential transaction.

Shares in the small-cap cannabis company have not been trading since the start of today. Consequently, the Elixinol share price remains at 19.5 cents.

What happened to Elixinol

The Elixinol share price will be one to watch in the coming days as its shares begin trading again. According to the release, the trading halt will remain in place until the announcement. Alternatively, when trading commences on March 8. Whatever is earlier.

The potential transaction is yet to be announced. Elixinol has stated that it wasn't aware of any reason why the halt should not be granted. 

Full year results

Notably, the company recently released its full-year results on February 26. Its shares have since nosedived, shedding around 9%.

Elixinol highlighted its global reset strategy. This has been put in place to stabilise its share price. For reference, the Elixinol share price has dropped an astounding 95.7% since May 2019. According to the company, the strategy has resulted in a strong balance sheet being formed. Ultimately, with lower costs and new growth catalysts. On this note, the cash at hand was $27.7 million at the time of reporting.
 
Furthermore, there was a significant margin improvement in the second half of FY2020. This comes as its business plan continues to shift more towards online and e-commerce. A sector with significant tailwinds.
 
Elixinol CEO Oliver Horn addressed the results saying:
While much of the past 12 months has been challenging for traditional retailers, we made great strides forward in our pursuit of sustainable growth and improved capital efficiency. Our strategy to reduce our cost base and shift the business towards higher margin channels, while bringing new products to market and entering new categories, is starting to show success via an improving bottom-line.
Mr. Horn also claimed the company is in a good position to benefit from the growing consumer trend for hemp wellbeing products. Despite his positive sentiment the market has struggled to make headway, falling 9% since the release.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Two smiling work colleagues discuss an investment at their office.
Broker Notes

Bell Potter names 3 sold-off ASX 200 shares to buy today

These shares have fallen heavily and a buying opportunity could have opened up.

Read more »

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a sour end to the trading week this Friday.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Broker Notes

Bell Potter just initiated coverage on this exciting ASX All Ords stock with a buy rating

There could be 30%+ upside for investors with this one.

Read more »

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices.
Share Market News

Buy, hold, sell: Evolution Mining, HomeCo, and Macquarie shares

Morgans has been looking at these shares this week. How does it rate them?

Read more »

Two brokers pointing and analysing a share price.
Bank Shares

Brokers re-rate CBA and ANZ shares after banks stun the market

ANZ shares reached a record $40.95 on Friday while CBA lifted to $179.27 before reversing course.

Read more »

Smiling man working on his laptop.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why Austal, Cochlear, Nick Scali, and WiseTech shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A businesswoman exhales a deep sigh after receiving bad news, and gets on with it.
52-Week Lows

13 ASX 200 shares hit multi-year lows as the market takes a breather

The market is down on Friday after a strong week that saw the ASX 200 lift to a 14-week high…

Read more »